Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ASTS vs MRNA✓SelectedUSD · MRNAASTS vs MRNA performance historyLatest closeAs of-8.92%11/20
Stock and ETF performance explorer

ASTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-54.1%
MRNA return
+697.5%
Excess return
-751.6%
Maximum drawdown
-82.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.9%-2.2%-6.8%-8.8%
7D-28.6%-12.7%-15.9%-28.0%
30D-43.1%-20.7%-22.4%-42.2%
3M-64.2%+46.3%-110.5%-64.9%
6M-74.0%+305.2%-379.3%-79.6%
YTD-68.0%+561.2%-629.2%-80.6%
1Y-54.1%+772.1%-826.2%-78.4%
All-54.1%+697.5%-751.6%-78.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling